{"id":626771,"title":"Guidance Document - Comparative Bioavailability Standards: Formulations Used for Systemic Effects - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-28","captureTimestamp":"2026-02-28T00:49:46.715000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/bioavailability-bioequivalence/comparative-bioavailability-standards-formulations-used-systemic-effects.html","snippet":"Guidance Document - Comparative Bioavailability Standards: Formulations Used for Systemic Effects (PDF Version - 319 K) Date Adopted: 2012/12/08 Revised Date: 2018/06/08 Effective Date: 2018/09/01 (for submissions filed on or after September 1, 2018) Please refer to the Notice to…","rawSnapshotUrl":"/api/snapshots/raw/626771","browseUrl":"https://replay.healtharchive.ca/job-6/20260228004946/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/bioavailability-bioequivalence/comparative-bioavailability-standards-formulations-used-systemic-effects.html#ha_snapshot=626771","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}